National Institutes of Health· United States · 17d
Immune Tolerance Network (UM1 Clinical Trial Required)
Conditions apply. Read the eligibility section below before you start.
At a glance
- Where
- United States
- Closes
- Posted
- How to apply
- On their website
Opens on their website. We are not involved in the application.
About this opportunity
<p>The purpose of this notice of funding opportunity (NOFO) is to support applications to continue the Immune Tolerance Network (ITN). The primary objective of the Network is to develop tolerogenic therapies for immune-mediated disorders. The three main clinical areas of work are: 1) Allergic diseases and asthma; 2) Autoimmune diseases; and 3) Immune-mediated consequences of transplantation. The core functions of the ITN include designing, conducting, and sharing the results of clinical trials and performing integrated mechanistic studies.</p>
Who may apply
- No country restriction stated
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Know someone this suits?
Sharing is how most people here hear about an opportunity in time.